B. Regulatory Agencies 
Food and Drug Administration 
4 
Concern was expressed with large scale experiments, but it was felt 
that FDA liaison membership on the RAC would resolve this. 
Environmental Protection Agency 
Dr. Murray cited the main concerns with protection of the 
environment and voluntary controls that were contained in 
Mr. Costle's letter. No problems were reported by EPA on the 
proposed procedures. 
Occupational Safety and Health Administration 
The OSHA representative reported that some of the issues raised in 
Dr. Bingham's letter are addressed by the proposed procedures. 
Specific recommendations made by OSHA on the Proposed Revised 
Guidelines were mentioned; in particular, that grievance procedures 
are needed to cover those States not under OSHA. 
Nuclear Regulatory Commission 
No comments on or problems with the PRG were reported. 
C. Other Agencies 
Department of Interior 
No comment was made on the Guidelines. 
Department of Commerce 
Concern over problems with proprietary data were registered. Input 
from private industry has been sought which indicates a willingness 
to follow the Guidelines but a concern over protection of 
proprietary information. Commerce reported an interest by private 
industry in NIH/ORDA advice. 
Department of Transportation 
It was reported that a letter from DoT has been sent raising 
concern over Guideline language regarding shipment. DoT reports 
that it currently cannot regulate shipment of recombinant DNA 
molecules . 
[ 430 ] 
